Cargando…

Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?

To date, many population pharmacokinetic models of antibiotics have been developed using blood sampling data after the fourth or fifth dose, which represents steady-state levels. However, if a model developed using blood sampled after the first dose is equivalent to that using blood sampled after th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, So Won, Kim, Dong Jin, Zang, Dae Young, Lee, Dong-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558941/
https://www.ncbi.nlm.nih.gov/pubmed/32947890
http://dx.doi.org/10.3390/ph13090249
_version_ 1783594747534770176
author Kim, So Won
Kim, Dong Jin
Zang, Dae Young
Lee, Dong-Hwan
author_facet Kim, So Won
Kim, Dong Jin
Zang, Dae Young
Lee, Dong-Hwan
author_sort Kim, So Won
collection PubMed
description To date, many population pharmacokinetic models of antibiotics have been developed using blood sampling data after the fourth or fifth dose, which represents steady-state levels. However, if a model developed using blood sampled after the first dose is equivalent to that using blood sampled after the fourth dose, it would be advantageous to utilize the former. The aim of this study was to investigate the effect of blood sampling after the first and/or fourth drug administration on the accuracy and precision of parameter estimates. A previously reported robust, two-compartment model of vancomycin was used for simulation to evaluate the performances of the parameter estimates. The parameter estimation performances were assessed using relative bias and relative root mean square error. Performance was investigated in 72 scenarios consisting of a combination of two blood sampling periods (the first and fourth dose), two total clearances, three infusion times, and four sample sizes. The population pharmacokinetic models from data collected at the first dose and those collected at the fourth dose produced parameter estimates that were similar in accuracy and precision. This study will contribute to increasing the efficiency and simplicity of antibiotic pharmacokinetic studies.
format Online
Article
Text
id pubmed-7558941
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75589412020-10-26 Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose? Kim, So Won Kim, Dong Jin Zang, Dae Young Lee, Dong-Hwan Pharmaceuticals (Basel) Article To date, many population pharmacokinetic models of antibiotics have been developed using blood sampling data after the fourth or fifth dose, which represents steady-state levels. However, if a model developed using blood sampled after the first dose is equivalent to that using blood sampled after the fourth dose, it would be advantageous to utilize the former. The aim of this study was to investigate the effect of blood sampling after the first and/or fourth drug administration on the accuracy and precision of parameter estimates. A previously reported robust, two-compartment model of vancomycin was used for simulation to evaluate the performances of the parameter estimates. The parameter estimation performances were assessed using relative bias and relative root mean square error. Performance was investigated in 72 scenarios consisting of a combination of two blood sampling periods (the first and fourth dose), two total clearances, three infusion times, and four sample sizes. The population pharmacokinetic models from data collected at the first dose and those collected at the fourth dose produced parameter estimates that were similar in accuracy and precision. This study will contribute to increasing the efficiency and simplicity of antibiotic pharmacokinetic studies. MDPI 2020-09-16 /pmc/articles/PMC7558941/ /pubmed/32947890 http://dx.doi.org/10.3390/ph13090249 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, So Won
Kim, Dong Jin
Zang, Dae Young
Lee, Dong-Hwan
Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?
title Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?
title_full Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?
title_fullStr Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?
title_full_unstemmed Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?
title_short Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?
title_sort impact of sampling period on population pharmacokinetic analysis of antibiotics: why do you take blood samples following the fourth dose?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558941/
https://www.ncbi.nlm.nih.gov/pubmed/32947890
http://dx.doi.org/10.3390/ph13090249
work_keys_str_mv AT kimsowon impactofsamplingperiodonpopulationpharmacokineticanalysisofantibioticswhydoyoutakebloodsamplesfollowingthefourthdose
AT kimdongjin impactofsamplingperiodonpopulationpharmacokineticanalysisofantibioticswhydoyoutakebloodsamplesfollowingthefourthdose
AT zangdaeyoung impactofsamplingperiodonpopulationpharmacokineticanalysisofantibioticswhydoyoutakebloodsamplesfollowingthefourthdose
AT leedonghwan impactofsamplingperiodonpopulationpharmacokineticanalysisofantibioticswhydoyoutakebloodsamplesfollowingthefourthdose